Press release
Vagus Nerve Stimulator Market: Influence of Rising Mental Health Awareness 2032
Vagus Nerve Stimulator Market
The global Vagus Nerve Stimulator (VNS) Market focuses on the development and commercialization of implantable and non-invasive neuromodulation devices designed to stimulate the vagus nerve for therapeutic purposes. These devices are widely used to treat neurological and psychiatric disorders such as epilepsy, depression, and migraine. VNS therapy improves patient outcomes by modulating brain activity and reducing symptom frequency and severity.
Market growth is supported by the rising prevalence of treatment-resistant neurological disorders, increasing demand for non-pharmaceutical therapies, and rapid technological innovations such as closed-loop VNS systems, wearable devices, and AI-integrated neurostimulators. Supportive regulatory approvals and increasing clinical trials further strengthen market momentum.
North America leads the global market due to its advanced healthcare infrastructure, early technology adoption, and presence of major players such as Medtronic plc, LivaNova plc, and electroCore Inc. Asia Pacific is the fastest-growing region, driven by rising healthcare awareness, an aging population, and increased investments in neuroscience research and medical devices.
Market Performance & Forecasts
Market Size (2024): USD 552.74 Mn
Forecast Period: 2025-2032
CAGR (2025-2032): 11.3%
Expected Market Size (2032): USD 1,301.61 Mn
The market is projected to expand steadily, driven by technological advancements, broader clinical applications, and growing adoption of both implantable and non-invasive VNS devices.
Get a sample of the report@https://www.maximizemarketresearch.com/request-sample/31173/
Key Market Trends for 2026
Shift Toward Non-Invasive VNS: Rising use of handheld and wearable devices like gammaCore due to ease of use, safety, and cost-effectiveness.
Expanded Therapeutic Applications: VNS increasingly explored for stroke rehabilitation, tinnitus, obesity, Alzheimer's disease, and PTSD.
AI & Smart Therapy Integration: Adoption of AI-based closed-loop systems for personalized stimulation and real-time therapy optimization.
Growth in Wearable Neuromodulation: Increased patient preference for portable, home-based therapy devices.
Regulatory Acceleration: Faster approvals for non-invasive VNS technologies across major markets.
Market Dynamics: What's Driving Growth
The Vagus Nerve Stimulator Market is shaped by innovation in neuromodulation technology, growing clinical evidence supporting VNS efficacy, and increasing demand for alternative treatments to pharmaceutical therapies. Rising healthcare investments and supportive reimbursement frameworks in developed regions further enhance adoption rates.
Key Market Drivers
Rising prevalence of epilepsy, depression, and migraine
Increasing demand for non-pharmaceutical and minimally invasive therapies
Technological advancements in closed-loop and AI-enabled VNS devices
Expanding clinical trials and regulatory approvals
Growing healthcare expenditure in developed economies
Rising awareness of neuromodulation therapies
Market Opportunities
Expansion of non-invasive VNS devices in emerging markets
Development of VNS applications for stroke rehabilitation, tinnitus, and neurodegenerative diseases
Strategic partnerships between device manufacturers and healthcare providers
Integration of AI and IoT for personalized neuromodulation therapy
Increasing telemedicine adoption for remote VNS therapy monitoring
Major Market Challenges
High cost of implantable VNS devices and surgical procedures
Limited access to advanced neuromodulation therapies in emerging economies
Low treatment rates for neurological disorders in developing regions
Patient preference for traditional medication therapies
Regulatory complexities for new neuromodulation technologies
Get access to the full description of the report @https://www.maximizemarketresearch.com/market-report/global-vagus-nerve-stimulator-market/31173/
Market Segmentation
By Product
Implantable VNS Devices
External (Non-Invasive) VNS Devices
By Application
Depression
Epilepsy
Migraine
By Biomaterial
Ceramics
Metallic
Polymeric
By End User
Hospitals
Ambulatory Surgical Centers
Others
Leading Global Players
Medtronic plc (U.S.)
electroCore, Inc. (U.S.)
MicroTransponder, Inc. (U.S.)
Boston Scientific Corporation (U.S.)
NeuroPace, Inc. (U.S.)
Soterix Medical Inc. (U.S.)
LivaNova plc (UK)
Cerbomed GmbH (Germany)
PINS Medical Co., Ltd. (China)
Japan Lifeline Co., Ltd. (Japan)
Regional Dominance
North America
North America dominates the global VNS market due to advanced healthcare infrastructure, strong reimbursement frameworks, high R&D investments, and the presence of major manufacturers. Government initiatives for neurological disorder awareness and rising healthcare spending further support market leadership.
Asia Pacific
Asia Pacific is the fastest-growing region, driven by rising healthcare awareness, an aging population, increasing disposable incomes, and expanding investments in neuroscience research and medical device manufacturing.
To know the most attractive segments, click here for a free sample of the report:https://www.maximizemarketresearch.com/request-sample/31173/
Recent Developments & Industry Trends
June 2025: LivaNova plc reported a 77% reduction in tonic-clonic seizures in drug-resistant epilepsy patients.
March 2025: MicroTransponder secured USD 65M in Series F funding to scale operations and expand R&D for its Vivistim Paired VNS System.
June 2024: LivaNova announced positive outcomes from its depression trial for VNS therapy in unipolar depression patients.
2024: Boston Scientific expanded its neuromodulation segment through acquisitions, including Baylis Medical and Axonics.
June 2023: electroCore's gammaCore device was added to the NHS Supply Chain list for migraine and cluster headache treatment.
FAQs
Q1. What is a vagus nerve stimulator?
A vagus nerve stimulator is a medical device that delivers electrical impulses to the vagus nerve to treat neurological and psychiatric disorders such as epilepsy, depression, and migraine.
Q2. What is driving the growth of the VNS market?
Key drivers include rising neurological disorder prevalence, increasing demand for non-pharmaceutical therapies, technological advancements, and expanding clinical approvals.
Q3. Which region dominates the VNS market?
North America currently dominates due to strong healthcare infrastructure, high R&D investment, and the presence of leading manufacturers.
Q4. What are the main types of VNS devices?
The market is segmented into implantable VNS devices and non-invasive (external) VNS devices.
Q5. What is the future outlook of the VNS market?
The market is expected to grow at a CAGR of 11.3% from 2025 to 2032, reaching nearly USD 1.30 billion by 2032, driven by innovation and expanding therapeutic applications.
Related Market Research Reports
global peptide and anticoagulant drugs market https://www.maximizemarketresearch.com/market-report/global-peptide-and-anticoagulant-drugs-market/67227/
DNA Synthesizer Market https://www.maximizemarketresearch.com/market-report/dna-synthesizer-market/189258/
Most Performing Reports
Healthcare Security Systems Market https://www.maximizemarketresearch.com/market-report/healthcare-security-systems-market/188190/
Digestive Health Market https://www.maximizemarketresearch.com/market-report/digestive-health-market/165193/
Weight Loss Supplements Market https://www.maximizemarketresearch.com/market-report/weight-loss-supplements-market/219979/
Makeup Remover Pen Market https://www.maximizemarketresearch.com/market-report/makeup-remover-pen-market/146350/
Freezer Market https://www.maximizemarketresearch.com/market-report/freezer-market/194552/
Analytics Partner
https://www.mmrstatistics.com/
MMRStatistics is an advanced market intelligence platform delivering data-driven insights, forecasts, and industry trends across global markets. Powered by differentiated research modules-covering market sizing, competitive analysis, and future outlooks-it helps businesses decode complex industries with clarity. Unlike traditional market research firms, MMRStatistics blends primary research, secondary data, and analytical frameworks into actionable intelligence. Flexible subscription plans provide scalable access, from snapshot insights to enterprise-grade market reports.
Connect with us:
MAXIMIZE MARKET RESEARCH PVT. LTD.
2nd Floor, Navale IT park Phase 3,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
+91 9607365656
sales@maximizemarketresearch.com
About Maximize Market Research:
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Vagus Nerve Stimulator Market: Influence of Rising Mental Health Awareness 2032 here
News-ID: 4354687 • Views: …
More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.
Circadian Rhythm Sleep Disorders Market: Increasing Adoption of Light Therapy So …
Circadian Rhythm Sleep Disorders Market Overview
The Global Circadian Rhythm Sleep Disorders (CRSD) Market was valued at US$ 0.92 Billion in 2023 and is expected to reach US$ 1.33 Billion by 2030, growing at a CAGR of 5.33% during the forecast period. Circadian rhythm sleep disorders are disruptions in the body's internal biological clock that regulate sleep-wake cycles, hormone secretion, alertness, and body temperature. These disorders lead to symptoms such as…
Catheters Market: Growth Driven by Increasing Chronic Disease Prevalence 2030
Catheters Market Overview
The global Catheters Market comprises a wide range of thin, flexible medical tubes used for therapeutic and diagnostic purposes across cardiovascular, neurovascular, urological, intravenous, and specialty applications. These devices are manufactured using medical-grade materials such as silicone rubber, latex, PVC, nylon, and polyurethane, and are essential for fluid drainage, medication delivery, gas administration, and minimally invasive procedures.
Catheters are extensively used in acute care settings for post-operative fluid management,…
Amniotic Membrane Market: Evolving Trends in Cryopreserved and Dehydrated Produc …
Amniotic Membrane Market Overview
The Global Amniotic Membrane Market was valued at USD 1.56 Billion in 2024 and is expected to reach USD 3.26 Billion by 2032, growing at a CAGR of 9.65% during the forecast period. Amniotic membrane is the innermost layer of the fetal membrane that protects and supports the developing fetus. It is composed of an epithelial layer, a basement membrane, and a stromal matrix, and is widely…
Alloy Wheel Market Analysis Reveals Increasing OEM and Aftermarket Demand
Alloy Wheel Market size was valued at USD 20.02 Bn. in 2024, and the total Alloy Wheel Market revenue is expected to grow by 7.1% from 2025 to 2032, reaching nearly USD 34.66 Bn.
Alloy Wheel Market Overview:
The alloy wheel market focuses on wheels manufactured using lightweight metal alloys, primarily aluminum and magnesium, designed to improve vehicle performance, safety, and appearance. Alloy wheels are widely used in passenger cars, SUVs, commercial…
More Releases for VNS
Global External VNS Devices Market to Reach USD 449.92 Million by 2030
The Global External VNS (Vagus Nerve Stimulation) Devices Market was valued at USD 268.27 million in 2024 and is projected to reach USD 449.92 million by 2030, growing at a CAGR of 9% during the forecast period (2025-2030).
Request Sample @ https://virtuemarketresearch.com/report/external-vns-devices-market/request-sample
The market's steady expansion is attributed to growing awareness about neurological disorders, advancements in non-invasive neuromodulation technologies, and the increasing preference for device-based therapies over traditional pharmaceutical treatments.
A long-term…
Innovative Product WONZ ta-VNS Device Featured at IFA 2025
WONZ Technology Debuts at IFA: Innovative Solution for Sleep Problems, Wellness, and More
At this year's IFA International Consumer Electronics Show, WONZ Technology showcased its latest innovative product - the ta-VNS Device, offering global users a new solution for sleep and health support.
Image: https://www.globalnewslines.com/uploads/2025/09/89524a31cf583837122ef3a71f94d595.jpg
As one of the standout health technology products at the exhibition this year, the WONZ ta-VNS Device distinguished itself from numerous innovative products with its cutting-edge vagus nerve…
External VNS Device Market Size, Share and Growth Report, 2034
On May 9, 2025, Exactitude Consultancy., Ltd. released a research report titled "External VNS Device Market". This report covers the global External VNS Device market sales, sales volume, price, market share, ranking of major companies, etc., and provides a detailed analysis by region, country, product type, and application. It also forecasts the market size of automotive kick sensors based on market patterns from 2020 to 2034 and future market trends.…
American MSB VNS Ltd. Announces Global Market Expansion
Large-Scale Entry into Asia and Africa
California, United States - June 21, 2024 - American MSB VNS Ltd (VNS) is pleased to announce that the company will expand into Asia and Africa on a large scale. As an innovation-driven Internet advertising company, VNS is committed to providing excellent advertising promotion services through its system service platform in cooperation with the world's top online shopping malls and social platforms.
Company Profile and Business…
Vagus Nerve Stimulation (VNS) Market Trends, Size, Share, Company Overview, Grow …
Global Vagus Nerve Stimulation (VNS) Market Analysis 2026 Report provides strategists, marketers and senior management with the critical information they need to assess the global Vagus Nerve Stimulation (VNS) Market as it emerges from the Covid-19 shut down. The impact of Coronavirus (COVID-19) on global market has reinforced many trends already shaping the industry pre COVID-19, There is a long-term trend towards the repositioning of players as entertainment providers on…
Vagus Nerve Stimulation (VNS) Devices Market to Witness Robust Expansion by 2024
LP INFORMATION offers a latest published report on Vagus Nerve Stimulation (VNS) Devices Market Analysis and Forecast 2019-2024 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Vagus Nerve Stimulation (VNS) Devices market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from…
